Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapy

Platinum-based chemoradiotherapy (CRT) is a standard front-line treatment for locally advanced non-small cell lung cancer (NSCLC). However, no clinical trials have compared the efficacy and toxicity of platinum combination and docetaxel as subsequent re-challenge chemotherapies after cancer recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Hisao, Kaira, Kyoichi, Mori, Keita, Ono, Akira, Akamatsu, Hiroaki, Taira, Tetsuhiko, Yoshino, Reiko, Kenmotsu, Hirotsugu, Saitoh, Jun-ichi, Harada, Hideyuki, Naito, Tateaki, Murakami, Haruyasu, Tomizawa, Yoshio, Matsuura, Masana, Saito, Ryusei, Nakajima, Takashi, Yamada, Masanobu, Takahashi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395619/
https://www.ncbi.nlm.nih.gov/pubmed/25897409
http://dx.doi.org/10.1186/s40064-015-0929-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395619/
https://www.ncbi.nlm.nih.gov/pubmed/25897409
http://dx.doi.org/10.1186/s40064-015-0929-3

Ejemplares similares